TechInnovation 2023: Paving the Path to Innovation Excellence asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.
Both parties inked an MOU to accelerate integration of AI-powered solutions into clinical care, to support Singapore's healthcare transformation SINGAPORE, July 7, 2022 /PRNewswire/ ASUSandTan Tock Seng Hospital (TTSH) inked a three-year Memorandum of Understanding (MOU) earlier today to formalise their collaborative efforts on building a more robust healthcare system to meet the evolving needs of patients. Since 2021, both parties have been working on novel AI solutions to enhance the value of clinical care delivered to patients. One notable result of this collaboration is Blade, an AI-powered software co-developed by engineers from ASUS Intelligent Cloud Services (AICS) and medical professionals from TTSH. Blade is aimed at automating peripheral blood cell identification in the laboratory setting. The traditional method of reviewing peripheral blood film is by light microscopy, performed by a laboratory technologist. This is labour intensive and can be subject to human fatigue.
Diagnosing leukaemia as well as diseases such as dengue and Covid-19 may soon be faster and more accurate with the use of artificial intelligence (AI).
18:31 mins
Synopsis: This is a fortnightly podcast series on Wednesdays by The Straits Times that aims to help you make sense of health matters that affect you.
Clinical trials are research studies that are usually conducted with healthy volunteers to gain more information about a potential treatment or vaccine and its effect on humans. There are various trials conducted here, including one for a potential Covid-19 vaccine that is being developed by Arcturus Therapeutics in the United States and the Duke-NUS Medical School in Singapore.
Some people have volunteered for the phase two vaccine trial, conducted at Tan Tock Seng Hospital s P.H. Feng Research Centre.